Clinical Trial

Simplified, Scalable, 24-hour Adaptive DBS in Parkinson's Disease

Study acronym: Subgaleal aDBS
Recruiting
View on ClinicalTrials.gov →
Summary
The purpose of this study is to test a new way to treat Parkinson's disease (PD). Subjects will be implanted with deep brain stimulator (DBS) devices and electrodes placed under the scalp. The main questions it aims to answer are: * Is there a less invasive method to collect useful brain signals? Find out if these brain signals can be related to movement and/or sleep symptoms. * How to use these brain signals to tailor adaptive deep brain stimulation settings for movement and/or sleep symptoms Researchers will compare study derived adaptive DBS settings to subject's clinically programmed continuous DBS settings to see which is better at treating patients PD symptoms.
Protocol Amendment History 1 change
critical Recruitment opened 2026-05-06
Trial Details
NCT Number NCT07398157
Lead Sponsor University of California, San Francisco
Collaborators: National Institute of Neurological Disorders and Stroke (NINDS)
Conditions PD - Parkinson's Disease
Enrollment 24 participants
Start Date 2026-04-09
Primary Completion 2029-11-30 (estimated)
Study Completion 2031-11-30 (estimated)
Updated on ClinicalTrials.gov 2026-05-05